Resultsbee.com

2121 Santa Monica Blvd Garden Level,Santa Monica,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(131) 058 - 2710

1245 Wilshire Blvd Suite 303,Los Angeles,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(180) 020 - 3551

240 South Jackson Street Suite 109,Glendale,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(180) 020 - 3551

1513 S. Grand Ave Suite 400,Los Angeles,CA

Premal Sanghavi, MD, FACS, is a board-certified, fellowship-trained oncoplastic breast surgeon practicing in downtown Los Angeles and Glendale, California. She completed her general surgery residency training from North Oakland Medical Centers/Wayne State University and breast surgery fellowship training in breast oncoplastic surgery at the University of Southern California in Los Angeles. Dr. Sanghavi is a firm believer in patient-centered care. Her goal is to provide optimal patient care, minimizing the psychological and physical distress thats caused when a woman is diagnosed with breast cancer. Dr. Sanghavis scope of practice includes the treatment of both benign and malignant breast diseases. Surgeries performed include oncoplastic breast surgery, lumpectomy, mastectomy, intraoperative radiation therapy for breast cancer, sentinel lymph node biopsy, and excisional biopsies for benign lesions. Her personal philosophy is Always and only follow your heart, be strong and never give up! Dr. Sanghavi welcomes new patients to Premal Sanghavi MD, Inc.

(121) 332 - 8093

222 W. Eulalia Suite 100 C,Glendale,CA

Premal Sanghavi, MD, FACS, is a board-certified, fellowship-trained oncoplastic breast surgeon practicing in downtown Los Angeles and Glendale, California. She completed her general surgery residency training from North Oakland Medical Centers/Wayne State University and breast surgery fellowship training in breast oncoplastic surgery at the University of Southern California in Los Angeles. Dr. Sanghavi is a firm believer in patient-centered care. Her goal is to provide optimal patient care, minimizing the psychological and physical distress thats caused when a woman is diagnosed with breast cancer. Dr. Sanghavis scope of practice includes the treatment of both benign and malignant breast diseases. Surgeries performed include oncoplastic breast surgery, lumpectomy, mastectomy, intraoperative radiation therapy for breast cancer, sentinel lymph node biopsy, and excisional biopsies for benign lesions. Her personal philosophy is Always and only follow your heart, be strong and never give up! Dr. Sanghavi welcomes new patients to Premal Sanghavi MD, Inc.

(181) 820 - 8378

1450 San Pablo Street Suite 6200,Los Angeles,CA

Ketan M. Patel, MD, brings compassionate care and unique surgical skills, involving leading-edge microsurgical techniques, to the division of plastic and reconstructive surgery at Keck Medicine of USC. As a microsurgery specialist, Dr. Patel provides leading-edge microvascular procedures that give patients novel treatment options for reconstruction. From facial palsy to breast cancer reconstruction to complex lower limb salvage, Dr. Patel's unique skills help patients achieve ideal outcomes. He is one of the few surgeons in the world specially trained to perform lymphovenous bypass and vascularized lymph node transfers, innovative surgical procedures that may be effective for many patients to help reduce the swelling, pain and discomfort that occurs with lymphedema. Dr. Patel takes a patient-centered approach to his medical practice, focusing on meeting the specific needs of each individual patient. He is also an accomplished researcher who has published numerous articles and written several book chapters on achieving optimal aesthetic and reconstructive results for every patient.

(132) 344 - 2792